Interaction potential of the dual orexin receptor antagonist ACT-541468 with CYP3A4 and food: results from two interaction studies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interaction potential of the dual orexin receptor antagonist ACT-541468 with CYP3A4 and food: results from two interaction studies
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-04
DOI
10.1007/s00228-018-2559-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Accelerated Development of the Dual Orexin Receptor Antagonist ACT-541468: Integration of a Microtracer in a First-in-Human Study
- (2018) Clemens Muehlan et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A pharmacokinetic drug–drug interaction study between selexipag and midazolam, a CYP3A4 substrate, in healthy male subjects
- (2017) Pierre-Eric Juif et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468
- (2017) Alexander Treiber et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia
- (2016) Kathryn M. Connor et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Effects of CYP3A Modulators on the Pharmacokinetics of Naloxegol
- (2016) Khanh Bui et al. JOURNAL OF CLINICAL PHARMACOLOGY
- In vitroandin vivocharacterisation of the metabolism and disposition of suvorexant in humans
- (2016) Donghui Cui et al. XENOBIOTICA
- Discovery of (1R,2S)-2-{[(2,4-Dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide (E2006): A Potent and Efficacious Oral Orexin Receptor Antagonist
- (2015) Yu Yoshida et al. JOURNAL OF MEDICINAL CHEMISTRY
- In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects
- (2014) Erik Sjögren et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant
- (2014) Matthias Hoch et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic Interactions Between the Orexin Receptor Antagonist Almorexant and the CYP3A4 Inhibitors Ketoconazole and Diltiazem
- (2014) Jasper Dingemanse et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Discovery and development of orexin receptor antagonists as therapeutics for insomnia
- (2013) C J Winrow et al. BRITISH JOURNAL OF PHARMACOLOGY
- Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers
- (2013) Catherine Dutreix et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Drug-Drug Interaction Study of ACT-178882, a New Renin Inhibitor, and Diltiazem in Healthy Subjects
- (2013) Jasper Dingemanse et al. CLINICAL DRUG INVESTIGATION
- Time-Dependent Inhibition and Induction of Human Cytochrome P4503A4/5 by an Oral IAP Antagonist, LCL161, In Vitro and In Vivo in Healthy Subjects
- (2013) Shyeilla Dhuria et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The physiological role of orexin/hypocretin neurons in the regulation of sleep/wakefulness and neuroendocrine functions
- (2013) Ayumu Inutsuka et al. Frontiers in Endocrinology
- Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial
- (2012) P Hoever et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacokinetic interactions of almorexant with midazolam and simvastatin, two CYP3A4 model substrates, in healthy male subjects
- (2012) Matthias Hoch et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Different Durations and Formulations of Diltiazem on the Single-Dose Pharmacokinetics of Midazolam: How Long Do We Go?
- (2011) Evan J. Friedman et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist
- (2011) Paolo Bettica et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The orexin system: roles in sleep/wake regulation
- (2010) Takeshi Sakurai et al. Annals of the New York Academy of Sciences
- Hypocretins in the Control of Sleep and Wakefulness
- (2010) Patricia Bonnavion et al. Current Neurology and Neuroscience Reports
- Disposition and Metabolism of [14C]SB-649868, an Orexin 1 and 2 Receptor Antagonist, in Humans
- (2010) C. Renzulli et al. DRUG METABOLISM AND DISPOSITION
- Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
- (2008) Shu-Feng Zhou CURRENT DRUG METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started